Home
About
Services
Biomonitoring
Tobacco Harm Reduction
Bioanalysis of Cannabinoids
Bioanalytical Solutions for Pharma
see overview
Publications
Blog
en
/
de
/
Request
Home
About
Services
Biomonitoring
Tobacco Harm Reduction
Bioanalysis of Cannabinoids
Bioanalytical Solutions for Pharma
see overview
Publications
Blog
Request
en
/
de
/
Imprint
Privacy Policy
Cookies
Take advantage of our large method portfolio
Plan your bioanalytical needs with ABF
Dr. Max Scherer
General Manager / Test Facility Management
+49 89 4114796 11
max.scherer@abf-lab.com
Salutation
Mr.
Mrs.
Mx.
Topic
Biomonitoring
Tobacco Harm Reduction
Bioanalysis of Cannabinoids
Bioanalytical Solutions for Pharma
ABF
Other
Dr. Max Scherer
General Manager / Test Facility Management
+49 89 4114796 11
max.scherer@abf-lab.com
By submitting the form, you consent to ABF Analytisch-Biologicals Forschungslabor GmbH storing and processing your data to process your request in accordance with our
Privacy Policy.
ABF may contact you for marketing purposes by email, telephone or letter. You can revoke this consent at any time without giving reasons to ABF Analytisch-Biologicals Forschungslabor GmbH, Semmelweisstraße 5, 82152 Planegg or by email at widerruf@abf-lab.com with effect for the future.
Submit
Frequently searched biomarkers
8-iso-PGF2α
Nicotine (Nic)
NNAL
Cyanoethylvalin (CeVal)
3-Hydroxypropylmercapturic acid (3-HPMA)
Propylene glycol (PG)